- Filed
- Apr 24, 2024 12:00 AM ET
- Period of report
- —
Amendment.
Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2023 · Jun 9, 2023 | 62.73M sh |
| Shares Diluted | FY 2023 · Apr 30, 2023 | 63.78M sh |
| Shares Diluted | FY 2023 · Jan 31, 2023 | 69.16M sh |
| Shares Diluted | FY 2023 · Jan 31, 2023 | 63.63M sh |
| Shares Diluted | FY 2023 · Oct 31, 2022 | 62.2M sh |
| Shares Diluted | FY 2023 · Oct 31, 2022 | 70.35M sh |
| Shares Diluted | FY 2023 · Jul 31, 2022 | 63.33M sh |
| Shares Diluted | FY 2023 · Apr 30, 2022 | 70.47M sh |
| Shares Diluted | FY 2023 · Apr 30, 2021 | 59.43M sh |
| Capex restated | FY 2023 · Apr 30, 2023 | $77.8M |
| Capex | FY 2023 · Jan 31, 2023 | $52.58M |
| Capex | FY 2023 · Apr 30, 2022 | $56.41M |
| Capex | FY 2023 · Apr 30, 2021 | $9.86M |
| Operating Cash Flow restated | FY 2023 · Apr 30, 2023 | −$12.72M |
| Operating Cash Flow | FY 2023 · Jan 31, 2023 | −$15.87M |
| Operating Cash Flow | FY 2023 · Oct 31, 2022 | −$8.93M |
| Operating Cash Flow | FY 2023 · Jul 31, 2022 | −$5.09M |
| Operating Cash Flow | FY 2023 · Apr 30, 2022 | $9.47M |
| Operating Cash Flow | FY 2023 · Apr 30, 2021 | $31.18M |
| Long Term Debt | FY 2023 · Apr 30, 2023 | $49.14M |
| Cash And Equivalents | FY 2023 · Apr 30, 2023 | $38.54M |
| Cash And Equivalents | FY 2023 · Jan 31, 2023 | $59.92M |
| Cash And Equivalents | FY 2023 · Oct 31, 2022 | $77.29M |
| Cash And Equivalents | FY 2023 · Jul 31, 2022 | $115.14M |
| Cash And Equivalents | FY 2023 · Apr 30, 2022 | $126.17M |
| Cash And Equivalents | FY 2023 · Apr 30, 2021 | $169.92M |
| Stockholders Equity restated | FY 2023 · Apr 30, 2023 | $189.17M |
| Stockholders Equity | FY 2023 · Jan 31, 2023 | $185.12M |
| Stockholders Equity | FY 2023 · Oct 31, 2022 | $181.63M |
| Stockholders Equity | FY 2023 · Jul 31, 2022 | $178.8M |
| Stockholders Equity | FY 2023 · Apr 30, 2022 | $174.53M |
| Stockholders Equity | FY 2023 · Apr 30, 2021 | $77.74M |
| Stockholders Equity | FY 2023 · Apr 30, 2020 | $41.9M |
| Current Liabilities restated | FY 2023 · Apr 30, 2023 | $215.15M |
| Current Liabilities | FY 2023 · Jan 31, 2023 | $228.31M |
| Current Liabilities | FY 2023 · Oct 31, 2022 | $222.92M |
| Current Liabilities | FY 2023 · Jul 31, 2022 | $93.54M |
| Current Liabilities | FY 2023 · Apr 30, 2022 | $75.76M |
| Total Liabilities restated | FY 2023 · Apr 30, 2023 | $262.4M |
| Total Liabilities | FY 2023 · Jan 31, 2023 | $265.67M |
| Total Liabilities | FY 2023 · Oct 31, 2022 | $261.1M |
| Total Liabilities | FY 2023 · Jul 31, 2022 | $272.42M |
| Total Liabilities | FY 2023 · Apr 30, 2022 | $255.32M |
| Current Assets | FY 2023 · Apr 30, 2023 | $112.45M |
| Current Assets | FY 2023 · Jan 31, 2023 | $132.34M |
| Current Assets | FY 2023 · Oct 31, 2022 | $145.94M |
| Current Assets | FY 2023 · Jul 31, 2022 | $180.64M |
| Current Assets | FY 2023 · Apr 30, 2022 | $180.02M |
| Total Assets restated | FY 2023 · Apr 30, 2023 | $451.57M |
| Total Assets | FY 2023 · Jan 31, 2023 | $450.79M |
| Total Assets | FY 2023 · Oct 31, 2022 | $442.73M |
| Total Assets | FY 2023 · Jul 31, 2022 | $451.21M |
| Total Assets | FY 2023 · Apr 30, 2022 | $429.84M |
| Eps Diluted restated | FY 2023 · Apr 30, 2023 | $0.00 |
| Eps Diluted | FY 2023 · Jan 31, 2023 | $0.00 |
| Eps Diluted | FY 2023 · Jan 31, 2023 | $0.01 |
| Eps Diluted | FY 2023 · Oct 31, 2022 | −$0.01 |
| Eps Diluted | FY 2023 · Oct 31, 2022 | $0.00 |
| Eps Diluted | FY 2023 · Jul 31, 2022 | $0.02 |
| Eps Diluted | FY 2023 · Apr 30, 2022 | $1.84 |
| Eps Diluted | FY 2023 · Apr 30, 2021 | $0.06 |
| Eps Basic restated | FY 2023 · Apr 30, 2023 | $0.00 |
| Eps Basic | FY 2023 · Jan 31, 2023 | $0.00 |
| Eps Basic | FY 2023 · Jan 31, 2023 | $0.01 |
| Eps Basic | FY 2023 · Oct 31, 2022 | −$0.01 |
| Eps Basic | FY 2023 · Oct 31, 2022 | $0.01 |
| Eps Basic | FY 2023 · Jul 31, 2022 | $0.02 |
| Eps Basic | FY 2023 · Apr 30, 2022 | $2.08 |
| Eps Basic | FY 2023 · Apr 30, 2021 | $0.06 |
| Sga Expense | FY 2023 · Apr 30, 2023 | $27.88M |
| Sga Expense | FY 2023 · Jan 31, 2023 | $7.11M |
| Sga Expense | FY 2023 · Jan 31, 2023 | $20.32M |
| Sga Expense | FY 2023 · Oct 31, 2022 | $6.83M |
| Sga Expense | FY 2023 · Oct 31, 2022 | $13.21M |
| Sga Expense | FY 2023 · Jul 31, 2022 | $6.38M |
| Sga Expense | FY 2023 · Apr 30, 2022 | $21.23M |
| Sga Expense | FY 2023 · Apr 30, 2021 | $17.06M |
| Net Income restated | FY 2023 · Apr 30, 2023 | $259K |
| Net Income | FY 2023 · Jan 31, 2023 | −$247K |
| Net Income | FY 2023 · Jan 31, 2023 | $594K |
| Net Income | FY 2023 · Oct 31, 2022 | −$520K |
| Net Income | FY 2023 · Oct 31, 2022 | $841K |
| Net Income | FY 2023 · Jul 31, 2022 | $1.36M |
| Net Income | FY 2023 · Apr 30, 2022 | $127.67M |
| Net Income | FY 2023 · Apr 30, 2021 | $11.21M |
| Operating Income | FY 2023 · Apr 30, 2023 | $3.6M |
| Operating Income | FY 2023 · Jan 31, 2023 | $2.72M |
| Operating Income | FY 2023 · Jan 31, 2023 | $2.77M |
| Operating Income | FY 2023 · Oct 31, 2022 | −$2.68M |
| Operating Income | FY 2023 · Oct 31, 2022 | $51K |
| Operating Income | FY 2023 · Jul 31, 2022 | $2.74M |
| Operating Income | FY 2023 · Apr 30, 2022 | $15.42M |
| Operating Income | FY 2023 · Apr 30, 2021 | $12.24M |
| Gross Profit | FY 2023 · Apr 30, 2023 | $31.48M |
| Gross Profit | FY 2023 · Jan 31, 2023 | $9.83M |
| Gross Profit | FY 2023 · Jan 31, 2023 | $23.09M |
| Gross Profit | FY 2023 · Oct 31, 2022 | $4.15M |
| Gross Profit | FY 2023 · Oct 31, 2022 | $13.26M |
| Gross Profit | FY 2023 · Jul 31, 2022 | $9.12M |
| Gross Profit | FY 2023 · Apr 30, 2022 | $36.65M |
| Gross Profit | FY 2023 · Apr 30, 2021 | $29.31M |
| Revenue | FY 2023 · Apr 30, 2023 | $149.27M |
| Revenue | FY 2023 · Jan 31, 2023 | $38.02M |
| Revenue | FY 2023 · Jan 31, 2023 | $109.47M |
| Revenue | FY 2023 · Oct 31, 2022 | $34.76M |
| Revenue | FY 2023 · Oct 31, 2022 | $71.45M |
| Revenue | FY 2023 · Jul 31, 2022 | $36.69M |
| Revenue | FY 2023 · Apr 30, 2022 | $119.6M |
| Revenue | FY 2023 · Apr 30, 2021 | $95.87M |